Cannabis in Portugal

Prescriptions of medical cannabis remain low in Portugal. However, 2024 was marked by the introduction of five new cannabis-based medications, including one flower and four different oral solutions. Value sales of CBD and other non-intoxicating cannabinoids products became stagnant in Portugal, due to the continuous scrutiny from authorities, products being out of stock and strong price reductions, among other factors.

The Cannabis in Portugal market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market - legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2029 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Cannabis market
• Pinpoint growth sectors and identify factors driving change
• Understand the competitive environment, the market’s major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop.